0001209191-19-053543.txt : 20191017 0001209191-19-053543.hdr.sgml : 20191017 20191017202332 ACCESSION NUMBER: 0001209191-19-053543 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20191016 FILED AS OF DATE: 20191017 DATE AS OF CHANGE: 20191017 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Mamluk Roni CENTRAL INDEX KEY: 0001647053 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37500 FILM NUMBER: 191156493 MAIL ADDRESS: STREET 1: CHIASMA, INC. STREET 2: 60WELLS AVENUE CITY: NEWTON STATE: MA ZIP: 02459 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: CHIASMA, INC CENTRAL INDEX KEY: 0001339469 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 460 TOTTEN POND ROAD STREET 2: SUITE 530 CITY: WALTHAM STATE: MA ZIP: 02451 BUSINESS PHONE: 617-928-5300 MAIL ADDRESS: STREET 1: 460 TOTTEN POND ROAD STREET 2: SUITE 530 CITY: WALTHAM STATE: MA ZIP: 02451 FORMER COMPANY: FORMER CONFORMED NAME: CHIASMA INC DATE OF NAME CHANGE: 20050922 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2019-10-16 0 0001339469 CHIASMA, INC CHMA 0001647053 Mamluk Roni C/O CHIASMA, INC. 460 TOTTEN POND ROAD, SUITE 530 WALTHAM MA 02451 1 0 0 0 Common Stock 2019-10-16 4 M 0 10000 0.09 A 10000 D Common Stock 2019-10-16 4 S 0 10000 4.94 D 0 D Stock Option (Right to Buy) 0.09 2019-10-16 4 M 0 10000 0.00 D 2021-09-20 Common Stock 10000 61139 D The sale was effected pursuant to a Rule 10b5-1 trading plan dated November 19, 2018 adopted by the Reporting Person. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $4.78 to $5.00, inclusive. The reporting person undertakes to provide to Chiasma, Inc., any security holder of Chiasma, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. This option is fully vested and exercisable. /s/ Mark J. Fitzpatrick, Attorney-in-Fact 2019-10-17